Margaret G. McGlynn, Director at AMICUS THERAPEUTICS, INC. (FOLD), sold 15,000 shares at $13.03 ($195K) on 2023-01-13, disclosed to the SEC on 2023-01-17.
Open-market sale of $195k FOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2022-04-12 | $1.4M | — | Filing → |
| VRTX | SELL | 2022-04-04 | $2.6M | — | Filing → |
| VRTX | SELL | 2022-02-01 | $2.2M | — | Filing → |